Search company, investor...
Aeglea BioTherapeutics company logo

Aeglea BioTherapeutics

aegleabio.com

Founded Year

2013

Stage

IPO | IPO

Total Raised

$56M

Date of IPO

4/7/2016

Revenue

$0000 

About Aeglea BioTherapeutics

Aeglea BioTherapeutics operates as a biotechnology company. The company focuses on developing enzyme-based therapeutics in the field of amino acid metabolism. The company was founded in 2013 and is based in Austin Texas.

Headquarters Location

805 Las Cimas Pkwy Suite 100

Austin, Texas, 78746,

United States

512-942-2935

Loading...

Loading...

Aeglea BioTherapeutics Patents

Aeglea BioTherapeutics has filed 3 patents.

The 3 most popular patent topics include:

  • amino acid metabolism disorders
  • autosomal recessive disorders
  • clusters of differentiation
patents chart

Application Date

Grant Date

Title

Related Topics

Status

9/8/2017

8/4/2020

Clusters of differentiation, Experimental cancer drugs, Monoclonal antibodies, Immunology, Immune system

Grant

Application Date

9/8/2017

Grant Date

8/4/2020

Title

Related Topics

Clusters of differentiation, Experimental cancer drugs, Monoclonal antibodies, Immunology, Immune system

Status

Grant

Latest Aeglea BioTherapeutics News

Spyre Therapeutics raises $180M in private placement, pushing cash runway into second half of 2026

Dec 8, 2023

News Reporter Spyre Ther­a­peu­tics is pulling in $180 mil­lion in a pri­vate place­ment just a cou­ple of weeks af­ter it re­brand­ed from Ae­glea Bio­Ther­a­peu­tics. Spyre is sell­ing 6 mil­lion shares of its com­mon stock at $15 per share and 150,000 shares of its Se­ries B pre­ferred stock at $600 per share in a pri­vate place­ment. It’s ex­pect­ed to close around Dec. 11. The pri­vate place­ment will ex­tend the biotech’s cash run­way in­to the sec­ond half of 2026 and sup­port de­vel­op­ment of its pipeline for gen­er­al cor­po­rate pur­pos­es and work­ing cap­i­tal. Unlock this article instantly by becoming a free subscriber. You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news. SIGN UP

Aeglea BioTherapeutics Frequently Asked Questions (FAQ)

  • When was Aeglea BioTherapeutics founded?

    Aeglea BioTherapeutics was founded in 2013.

  • Where is Aeglea BioTherapeutics's headquarters?

    Aeglea BioTherapeutics's headquarters is located at 805 Las Cimas Pkwy, Austin.

  • What is Aeglea BioTherapeutics's latest funding round?

    Aeglea BioTherapeutics's latest funding round is IPO.

  • How much did Aeglea BioTherapeutics raise?

    Aeglea BioTherapeutics raised a total of $56M.

  • Who are the investors of Aeglea BioTherapeutics?

    Investors of Aeglea BioTherapeutics include Lilly Ventures, Novartis Venture Funds, Jennison Associates, RA Capital Management, UT Horizon Fund and 9 more.

Loading...

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.